Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG: IPH4502

Sponsor

Innate Pharma